Abstract:Objective To express in prokaryotic system and to analyze the antigenic specificity of EB virus(EBV) latent membrane protein 2(LMP2) multi-epitopes gene rich of T cell and B cell epitopes.Methods Using on-line prediction service, T cell epitopes and B cell epitopes of EB virus latent membrane protein 2 were predicted. The genes rich of CTL and th cell epitopes were selected as the candidate gene sequences, while B cell epitopes around them were taken into account. The finial selected multi-epitope gene was synthesized after being optimized according to prokaryotic codon bias and inserted into prokaryotic expression vector pET32a( + ) to get the recombinant plasmid: pET32a( + )/EBV-LMP2 multi-epitopes. After transformed into E. coli BL21 (DE3) and induced by IPTG, the target multi-epitopes gene can be expressed as Trx-His fusion protein. The expression products can be identified by SDS-PAGE and Western blot. Moreover, rabbit serum antibody to EBV membrane protein and nasopharyngeal carcinoma(NPC) patient serum were used respectively to detect the antigenic specificity of the multi-epitopes. Meanwhile, 6-8 weeks female BALB/c mice were immunized with EBV-LMP2 multi-epitope at 2 week intervals, three times in all, Trx-His protein and PBS were set as the control groups. At the second week after the last immunization, the mice were sacrificed. LDH and indirect ELISA were taken to detect the specific spleen CTL activityand specific IgG in serum, which reflected the immunogenicity of the EBV-LMP2 multi-epitope. Results Two amino acid sequences which locate at the LMP2 (aa195 -232 ) and LMP2 (aa419-436 ) were selected and connected in series to be the target gene. The recombinant plasmid containing EBV-LMP2 multi-epitope gene successfully constructed and the target protein was expressed in E. coli BL21 ( DE3 ). The relative molecular mass(Mr) of The expression products is about 27 × 103 , which matches up to the expected Mr. The antigenic specificity of the multi-epitopes protein was identified by Western blot and the multi-epitopes protein also can be detected by rabbit serum antibody to EBV membrane protein and NPC patient serum respectively. In the result of the animal experiment, EBV-LMP2 multi-epitope was able to induce the specific CTL activity in BALB/c mice. With the increasing of the effector: target ( E: T) 1: 5,1: 10, 1: 25, the CTL activity was also increased wih( 12.52% + 2.59% ), (21.80% + 1.08% ), (23.68% + 3.74% ) respectively; EBV-LMP2 multi-epitope was able to induce LMP2-specific antibody response(A490 =0.258 +0.040) as compared with Trx-His protein(A490 =0.095 +0.011) and PBS(A490 =0.068 +0.014,P＜0.05＝. Conclusion The EBV-LMP2 multi-epitopes gene was designed successfully and expressed precisely in prokaryotic expression system with good antigenicity and immunogenicity.

Expression and Purification of the DNA Binding Domain of the Epstein-Barr Virus Nuclear Antigen 1

Expression and Purification of HPV58 E1 Protein and Preparation of Polyclonal Antibodies against HPV 58 E1 Protein

Construction and expression of a spliced variant of Epstein-Barr virus bzlf1 and preparation of its polyclonal antibody.

[Expression, Purification and Activity Identification of ZtaN-p23 Fusion Protein in Escherichia Coli of Epstein-Barr Virus].

Structure-based design of antibodies targeting the EBNA1 DNA-binding domain to block Epstein-Barr virus latent infection and tumor growth

[Construction and Immunological Responses of Recombinant Adenovirus Containing Epstein-Barr Nuclear Antigen 1 in Mice].

Prokaryotic Expression and Antigen Characteristics of EB Virus Latent Membrane Protein 2 ( EBV-LMP2) Multi-Epitopes

Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region

Expression and Purification of HPV58 E1^E4 Fusion Protein and Preparation of Polyclonal Antibody Against HPV58 E1^E4

Renaturing and Antigenic Identification of Human EGF Receptor Extracellular Domain Inclusion Body Overexpressed in Escherichia Coli

A Potent and Protective Human Neutralizing Antibody Targeting a Novel Vulnerable Site of Epstein-Barr Virus

High-Level Expression Of Mycobacterium Tuberculosis Protein Espb In E. Coli And Preparation Of Novel Anti-Espb Monoclonal Antibodies

Expression of the Main Antigenic Domain in A3BCD of E2 Glycoprotein of Classical Swine Fever Virus in Escherichia coli

Construction and characterization of monoclonal antibodies specific for the R transactivator 185 of Epstein-Barr virus.

[Expression, Purification and Refolding of Extracellular Domain of Mouse Epidermal Growth Factor Receptor].

Expression and Purification of Single-Chain Anti-Hbx Antibody in Escherichia Coli

A Novel High Throughput Assay to Quantify Epstein-Barr Virus Neutralizing Antibody Activity Against B-cell and Epithelial Cell Infections for Vaccine and Therapeutic Developments.

Prokaryotic Expression of the H1 Subunit of the Asialoglycoprotein Receptor and the Preparation of Polyclonal Antibody

The Expression and Characterization of Highly Antigenic Region of Spike Protein of Prevalent Infectious Bronchitis Virus in Escherichia Coli

Prokaryotic Expression,purification and Polyclonal Antibody Preparation of C Terminal Helicase Domain of Mouse Rig-I

Purification and Application of C-terminally Truncated Hepatitis C Virus E1 Proteins Expressed in Escherichia Coli.